新股消息 | 健康160通过港交所聆讯 平台平均月活跃用户330万名

Core Viewpoint - Health 160 International Limited is preparing for its listing on the Hong Kong Stock Exchange, with Shenwan Hongyuan Hong Kong and Qianhai Capital acting as joint sponsors [1]. Company Overview - Health 160 is an experienced wholesale distributor of pharmaceutical health products and a leading provider of integrated digital healthcare services in China. The company offers a variety of pharmaceutical health products and comprehensive digital healthcare solutions [4]. - The company operates a digital healthcare service platform, Health 160, which connects healthcare institutions, healthcare professionals, and individual users, facilitating the digital transformation of the healthcare industry in China [5]. Digital Healthcare Solutions - The Health 160 platform integrates online and offline healthcare services, providing a diverse range of medical services, including serious and consumer healthcare services. The platform employs effective monetization strategies to generate revenue from various participants [5]. - As of March 31, 2025, the platform has connected over 44,600 healthcare institutions, including more than 14,400 hospitals (3,430 of which are tertiary hospitals) and over 30,200 grassroots healthcare institutions [5]. Partnerships and User Base - The company has established partnerships with over 902,300 healthcare professionals, including approximately 46,200 registered doctors. The platform has a substantial user base, with 55.2 million registered individual users and an average of 3.3 million monthly active users as of March 31, 2025 [6]. Financial Performance - The company's revenue for the years ending December 31 for 2022, 2023, and 2024, and for the three months ending March 31, 2025, was approximately RMB 526 million, RMB 629 million, RMB 621 million, and RMB 100 million, respectively. The company reported losses of approximately RMB 120 million, RMB 106 million, RMB 108 million, and RMB 17 million for the same periods [6][7].